Investors
DiagnoCure’s mission is to be the leading developer and provider of high-value diagnostics for the detection and management of cancer.
STOCK INFORMATION
| Symbol | TSX: CUR |
|---|---|
| Last trade | 1.45 |
| Open | 1.47 |
| Net change | -0.01 |
| High | 1.47 |
| Low | 1.41 |
| Volume | 58,750 |
| As of | 2010-03-11 15:58 EST |
| $CAN. Quotes are delayed. For information purposes only. |
|
Annual General Meeting of Shareholders
March 17, 2010, 2:00 pm
St-James Club
Montreal, Quebec